Agilent Bioanalyzer 2100 is based on microfluidics, electrophoresis, sensitive analyte binding dyes for sizing, and qualitative and quantitative analysis. The analyte can be protein, RNA, and DNA at concentrations below 500 pg. This platform has applications in NGS workflows, Microarray workflows, and analysis of low concentration samples. This makes it a versatile instrument that augments the existing MiSeq and Microarray facility and forms an essential component for studying Genomics, transcriptomics, and Proteomics.

DBT supported UDSCMAC facility at CIIDRET houses Agilent Bioanalyzer 2100. This facility with state-of-the-art instrumentation serves national R&D and academic establishments having DSIR authorization and Customs exemption such as colleges, public labs, government foundations, and not-for-benefits associations.

The facility has been exploited by several users across the country for their experiments.